Foodconsumer.org

 
USCards.com Bookmark Us
All Food, Diet and Health News 
 
 Misc. News
 Must-Read News
 Letter to Editor
 Featured Products
 Recalls & Alerts
 Consumer Affair
 Non-food Things
 Health Tips
 Interesting Sites
 
 Diet & Health
 Heart & Blood
 Cancer
 Body Weight
 Children & Women
 General Health
 Nutrition
 
 Food & Health
 Food Chemicals
 Biological Agents
 Cooking & Packing
 Technologies
 Agri. & Environ.
 Laws & Politics
 
 General Health
 Drug News
 Diseases
 Mental Health
 Infectious Disease
 Environment
 Lifestyle
 Government
 Other News
 
 Food Consumer
 FC News & Others
Search





Search Foodconsumer & Others


Add to Google
Add to My Yahoo
Newsfeed

foodconsumer.org news feed
Su bmit news[release]



More than 100 credit cards available at uscards.com from uscards.com, you can pick more than 100 credit cards


General Health : Infectious Disease Last Updated: Apr 20, 2011 - 9:38:09 AM


Tamiflu resistant influenza mutant on the rise
By Sue Mueller
Feb 1, 2008 - 9:39:21 AM

E.mail t.his a.rticle
 P.rinter f.riendly p.age
Get n.ewsletter
 
   

FRIDAY FEB 1, 2008 (Foodconsumer.org) -- A mutation found in a small percentage of the common influenza virus causing illness this winter in Europe, Canada and the United States makes the virus resistant to the anti-influenza drug Tamiflu, The New York Times cited the World Health Organization as saying Wednesday.

The predominant influenza virus strain found in the winter is influenza A/H1N1 and the Tamiflu-resistant form of the virus is known as influenza A (H1N1 H274Y).  The rate of the mutant varies among four European countries, Canada and the US.

In Norway, epidemiologists found the mutation was present in 12 of 16, or 75 percent, of viruses isolated from Norwegian patients in the earliest part of the influenza season, in November and December. This rate was highest among the four European countries - Britain, Denmark, France and Norway.

Overall, a survey of the mutation in 10 European countries by the European Center for Disease Prevention and Control showed the rate was 13 percent. When Norway was excluded, the rate was 5 percent.

In the United States, the Tamiflu resistant strain was found in 9 of 237 or 3.8 percent of patients who suffered either type A or type B in the winter. But because all 9 mutants were in the A(H1N1) category  the rate was 6.7 percent among A/H1N1 viruses, Dr Fry said in a telephone interview with the New York Times.

According to the New York Times, scientists were surprised by the finding that the A/H1N1 mutant was on the rise as they used to believe that mutations of this type would make the virus less potent and less likely to spread among people.

Health officials from the WHO and the US were cited by the times as saying that no immediate measures would be taken to change the use of Tamiflu or oseltamivir because the incidence of the mutant virus is still small although WHO officials said they were troubled by the findings.

Tamiflu is a drug that is used in the early stages of influenza to relieve its symptoms and patients treated with the antiviral drug could shorten the suffering period by one or two days. The drug is stockpiled by many countries in a bid to prevent a future influenza pandemic.

Officials downplayed the significance of the findings.  "Clearly, this is of global concern, but it is not a global problem now," Dr. Frederick G. Hayden, an influenza expert at the WHO, said in a telephone interview.

Scientists at the U.S. Centers for Disease Control and Prevention in Atlanta said the standard influenza vaccine still protects against the mutant virus.

It's unknown what caused the mutation. But use of Tamiflu may not be the cause.  Tamiflu is most commonly used in Japan, but the country is low in the incidence of the mutant influenza viruses.  On the contrast, Norway has the highest rate of the mutation although in the country doctors do not use Tamiflu to treat influenza, according to time.com.

Healthy people do not need any vaccine or antiviral drug to treat common influenza because the immune system has the capability to overcome the illness, a foodconsumer.org scientist suggested.





© 2004-2008 by foodconsumer.org unless otherwise specified

Top of Page




Google
 
Web foodconsumer.org

Search Consumer-friendly Health Sites












We have moved to Food Consumer . Org



disclaimer | advertising | jobs | privacy | about us | newsletter | Submit news/articles
link partners: | Buy Viagra | MarketAmerica.com |
Buy a home | Auto Insurance | Mortgage refinancing | DaytonaCPA.com | Take Your Blog to a Higher Level
© Copyright 2004 - 2008 foodconsumer.org All rights reserved

Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only. The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals. Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.